A
Indication details
- Control Arm
- Surgery alone (Meta-analysis)
- Therapeutic Indication
- Patients with resected stage II and III colon cancer
- Tumour Type
-
Gastrointestinal Cancers
- Tumour Sub-type
- Colon Cancer
- Tumour Stage
- Adjuvant
Primary Outcome(s)
- Primary Outcome(s)
- DFS and OS
- Evaluated Outcome
- OS
- Form(s)
- Form 1
Outcome Data
- OS Control
- 66.8% at 8-years
- OS Gain
- 5.4% at 8-years
Score (after adjustments)
- Curative score
-
A
Scorecard details
- ESMO-MCBS version
- ESMO-MCBS v1.1
- Scorecard ID
- 265
- Scorecard version
- 1
- Issue date
- 06.04.2021